Back
NeuroOne Medical Technologies 10K Form
Sell
28
NMTC
NeuroOne Medical Technologies
Last Price:
0.90
Seasonality Move:
89.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-12 | 10K | NMTC/NeuroOne Medical Technologies Annual |
| 2021-01-28 | 10K | NMTC/NeuroOne Medical Technologies Annual |
| 2020-12-09 | 10K | NMTC/NeuroOne Medical Technologies Annual |
| 2020-08-13 | 10Q | NMTC/NeuroOne Medical Technologies Quarterly |
| 2020-05-14 | 10Q | NMTC/NeuroOne Medical Technologies Quarterly |
| 2020-02-14 | 10Q | NMTC/NeuroOne Medical Technologies Quarterly |
Receive NMTC News And Ratings
See the #1 stock for the next 7 days that we like better than NMTC
NMTC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.95M |
|---|---|
| Cash Flow: | $-2.38M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.11 |
| Price / Book: | 9.11 |
Profitability
| EPS (TTM): | -0.48000 |
|---|---|
| Net Income (TTM): | $-12.1M |
| Gross Margin: | $456.52K |
| Return on Equity: | -282.05% |
| Return on Assets: | -201.81% |
NeuroOne Medical Technologies Earnings Forecast
Key NeuroOne Medical Technologies Financial Ratios
- The Gross Profit Margin over the past 8 years for NMTC is 23.38%.
- The Selling, General & Administrative Expenses for NMTC have been equal to 354.75% of Gross Profit Margin.
- The Research & Development expenses have been 355.49% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of NMTC is -607.42% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 5 years.
NeuroOne Medical Technologies Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NMTC |
| Website: | n1mtc.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.42 |
| Quick Ratio: | 1.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NMTC Technical Analysis vs Fundamental Analysis
Sell
28
NeuroOne Medical Technologies (NMTC)
is a Sell
Is NeuroOne Medical Technologies a Buy or a Sell?
-
NeuroOne Medical Technologies stock is rated a Sell
The current NeuroOne Medical Technologies [NMTC] share price is $0.89. The Score for NMTC is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.